![Hugh Wynne-Edwards](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hugh Wynne-Edwards
Plus aucun poste en cours
Historique de carrière de Hugh Wynne-Edwards
Anciens postes connus de Hugh Wynne-Edwards
Sociétés | Poste | Début | Fin |
---|---|---|---|
Welichem Biotech, Inc.
![]() Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Président | - | 08/04/2008 |
BC Research, Inc.
![]() BC Research, Inc. Miscellaneous Commercial ServicesCommercial Services BC Research, Inc. provides clinical research services. Its services include custom research, engineering, plant services and process commercialization services. The company is headquartered in Vancouver, Canada. | Fondateur | 01/01/1993 | - |
Formation de Hugh Wynne-Edwards
University of Aberdeen | Undergraduate Degree |
Queen's University | Doctorate Degree |
Statistiques
Internationale
Canada | 4 |
Royaume-Uni | 2 |
Opérationnelle
Chairman | 1 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Welichem Biotech, Inc.
![]() Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Health Technology |
BC Research, Inc.
![]() BC Research, Inc. Miscellaneous Commercial ServicesCommercial Services BC Research, Inc. provides clinical research services. Its services include custom research, engineering, plant services and process commercialization services. The company is headquartered in Vancouver, Canada. | Commercial Services |
- Bourse
- Insiders
- Hugh Wynne-Edwards
- Expérience